[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,496 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-05-27 | Class I | PS Seasoning & Spices, Inc.H-0815-2026 | Product was made with milk powder recalled by the supplier due to Salmonella contamination. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0795-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen contamination and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | LIQUID BLENZ CORPH-0782-2026 | May be under-processed resulting in growth of Clostridium botulinum and lists health claims. | Environmental Monitoring |
| 2026-05-27 | Class I | Solina U.S. HoldingH-0825-2026 | potential to be contaminated with Salmonella | Environmental Monitoring |
| 2026-05-27 | Class I | JOHN B SANFILIPPO & SONS INCH-0833-2026 | potential presence of Salmonella | Environmental Monitoring |
| 2026-05-27 | Class II | LIQUID BLENZ CORPH-0785-2026 | May be under-processed resulting in growth of Clostridium botulinum and lists health claims. | Environmental Monitoring |
| 2026-05-27 | Class I | Solina U.S. HoldingH-0828-2026 | potential to be contaminated with Salmonella | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0798-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0796-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | LIQUID BLENZ CORPH-0794-2026 | May be under-processed resulting in growth of Clostridium botulinum and lists health claims. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0797-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | LIQUID BLENZ CORPH-0787-2026 | May be under-processed resulting in growth of Clostridium botulinum and lists health claims. | Environmental Monitoring |
| 2026-05-27 | Class I | Ghirardelli Chocolate CompanyH-0842-2026 | Potential contamination with Salmonella. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0803-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0806-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | Llorens Pharmaceuticals International Division, Inc.H-0809-2026 | Foreign object: black particulate matter | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0800-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0801-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class I | Ghirardelli Chocolate CompanyH-0843-2026 | Potential contamination with Salmonella. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0804-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class I | JOHN B SANFILIPPO & SONS INCH-0831-2026 | potential presence of Salmonella | Environmental Monitoring |
| 2026-05-27 | Class I | JOHN B SANFILIPPO & SONS INCH-0834-2026 | potential presence of Salmonella | Environmental Monitoring |
| 2026-05-27 | Class I | Solina U.S. HoldingH-0829-2026 | potential to be contaminated with Salmonella | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0799-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class I | Ghirardelli Chocolate CompanyH-0845-2026 | Potential contamination with Salmonella. | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.